Blogs & News


BLOGS

The Value of Biopharmaceutical Innovation in the U.S.

There have been some negative reports recently regarding the pricing practices of some pharmaceutical companies. However, it is important to give at least equal consideration to the value derived from the intensive level of research and development undertaken by the biopharmaceutical industry in the U.S....

The Evolving Landscape of U.S. Payer Coverage Decisions: The Role of Health Economics and Outcomes Research

Although there are a large number of public and private payers in the U.S., medical device and pharmaceutical manufacturers generally focus on two types of payers: (1) Medicare, which is administered by the Centers for Medicare and Medicaid Services (CMS) and covers individuals ages ≥ 65; and (2) private commercial payers (e.g., Blue Cross and Blue Shield plans...

Will an Unravelling of the Affordable Care Act Result in Meaningful Organizational Changes in U.S. Medical Care? Implications for Economic Evaluation of Drugs & Devices

In recent years, there has been a shift in U.S. health care markets to a broader, population-based perspective when assessing the costs and benefits of medical innovation. Cost effectiveness analysis and budget impact analysis results can look quite different when viewed from the perspective of a health system or an accountable care organization...

Medical Device Economics and the Health System Purchaser in the Era of Novel Payment Mechanisms
May 31, 2016

Hospitals in the U.S. spend an estimated 40% of their annual budgets on supplies, medical devices and equipment alone. According to the American Hospital Association, in 2015 total expenditures by U.S. hospitals was $808...

Value-Based Payment for Oncology Services
March 7, 2016

Cancer care is a large part of overall health care expenditures. Of the approximately 18% of U.S. gross domestic product spent on healthcare, more than 5% is attributed to cancer treatments...

Why Medical Device Companies Need to Develop Economic Evidence in the U.S.
January 14, 2016

Although the U.S. lacks a centralized health technology evaluation agency, as many of the European countries maintain, in recent years there has been considerable pressure to control the rising costs ...

Reference Pricing for in vivo and in vitro Diagnostic Tests
November 16, 2015

Prices in health care vary widely even within the same local market and for similar tests and treatments. This reflects differences among providers in their ability and willingness to leverage ...

Purchasing Medical Innovation: The Implications for the Medical Device Industry
October 13, 2015

 In an earlier blog, we reviewed the recent book by one of Avalon’s directors, James Robinson. Robinson’s book, entitled “Purchasing Medical Innovation: The Right Technology, for the Right Patient, at the ...

Physician Shortages in the U.S.: Disentangling Myth, Folklore, and Fact
September 14, 2015

Much of the public media and even a substantial part of the medical literature operates on the assumption that there is a shortage of physicians in the U.S., including those ...

Controlling the Costs of Clinical Laboratory Testing in Medical Practice
August 20, 2015

Today’s clinical laboratory can do much more than you think. Advances in molecular diagnostics, genetics and biomarkers have ushered in a new era of clinical laboratory capabilities. Along with these ...

Fad Diets and Nutrition: What’s all the Fuss about Gluten?
August 13, 2015

In recent years, the food industry has seen a boom in the “free from” category, including a myriad of ingredients such as high fructose corn syrup, artificial flavors, toxic pesticides, ...

The New Era of Cost Control in Healthcare: What Should you look for in a Health Economics and Outcomes Research Consultant?
May 12, 2015

In recent years, there has been a small but measurable slowdown in the rate of increase in health expenditures, both here in the U.S. and abroad. The slowdown is largely ...

Paying for Specialty Pharmaceuticals: The Case of Injectable Oncology Drugs
April 28, 2015

According to the American Cancer Society, the financial costs of cancer are high for both the person with cancer and for society as a whole. The National Institutes of Health ...

Book Review: “Purchasing Medical Innovation: The Right Technology, for the Right Patient, at the Right Price,” by James C. Robinson
March 22, 2015

The demand for medical care services in the U.S. has long been the envy of other industries. Americans are generally not accustomed to going without, typically despise most non-market forms ...

Integration of Novel Diagnostics into Clinical Practice
February 28, 2015

Similar to drug and device markets, a critical part of the success of novel diagnostics is educating providers on clinical and therapeutic utility. However, unlike pharmaceutical drugs, the ordering of ...

The State of the Union and Innovation in Molecular Diagnostics
January 22, 2015

During the U.S. “State of the Union” address this past week, President Obama devoted some time to emphasizing the importance of “personalized medicine,” referring to the rapid pace of innovation ...

How Should Health Care Providers Measure and Market the Value of their Services?
December 31, 2014

There was a time when we did not spend a lot of time worrying about the quality of the health care services we received. Our families went to the doctor ...

The Long Reach of a Devastating Virus
November 24, 2014

As a follow-up to our previous blog (October 2014), we are revisiting the topic of Ebola because this public health crisis has drawn attention to two very important public health ...

Health Care Reform in Sub-Saharan Africa
October 28, 2014

The recent Ebola epidemic in Africa has served as a reminder of the vulnerability of public health systems in handling unexpected health problems, especially when basic access to care and ...

Environmental Health Update: Ending our Love Affair with Styrofoam
September 5, 2014

For over 50 years, the food industry has used Expanded Polystyrene (EPS) food service products for a variety of food and beverage service needs. EPS, commonly known as Styrofoam, is ...

What are the Health Consequences of Psychiatric Hospital Closures?
August 25, 2014

Over the past 50 years, 95% of the country’s state psychiatric hospital population have been closed down, leaving fewer than 200 hospitals to provide care to those living with mental ...

The Costs of Antibiotic Resistance and the Need for Antibiotic Stewardship
August 18, 2014

After suffering from a nasty cold for more than a few days, many of us think about checking in with our doctor just to be sure that it’s not something ...

Return-on-Investment of Workplace Health Promotion Programs
August 18, 2014

Recent healthcare reforms in the U.S. and abroad have emphasized the value of meaningful and effective preventative care and health promotion. Corporations are taking note, and, as a result, there ...

E-Cigarettes and Tobacco Policy
July 7, 2014

1. What is an E-Cig? The “e-cig” is an electronic cigarette that is used to simulate the experience of smoking that has a cartridge with a heater that vaporizes liquid nicotine ...

The Evolving Role of the New Generation of Molecular Diagnostics in U.S. Health Markets: Development, Clinical Integration, and Evaluation
July 6, 2014

The high cost of adverse events has been estimated to be at least US$177 billion per year in the U.S., and prescription drugs overall have efficacy only approximately 50% of ...

Nutrition Policy & Food Labeling in the U.S.: A Review & Update
July 6, 2014

The Organic and natural food industry has boomed in the last few decades, moving from a small niche market to a $30 billion dollar industry. Across the United States, people ...

Current Topics in Public Health: Heroin’s Revival
February 6, 2014

Heroin has a new face. According to statistics from the National Institute on Drug Abuse, it’s a white male in his 30s and 40s. Surprisingly, heroin use has grown in ...

The Economics of Ovarian Cancer Diagnosis
February 6, 2014

According to estimates from the World Health Organization, 8.3 million people worldwide died from cancer and other neoplasms in 2008—about 14% of all deaths. In the same year, the overall ...

Value-Based Purchasing for Hospital Services in the U.S.
January 15, 2014

The Center for Medicare and Medicaid Services (CMS) Value-Based Purchasing (VBP) program is an incentive-based repayment plan linked to the quality of care hospitals provide to Medicare patients. With VBP, ...

Reshaping the Clinical Laboratory in the Era of Patient-Centered Outcomes, Accountable Care Organizations, and Pharmacogenomics
December 2, 2013

In recent years there has been renewed attention devoted to coordination of medical care services across the continuum of care, particularly in the area of prevention, monitoring, diagnostics, and disease ...

How Big a Problem is Health Care Fraud and Abuse, and How Can We Detect It?
October 22, 2013

According to the National Health Care Anti-Fraud Association (NHCAA) and the Blue Cross and Blue Shield Association, the estimated annual costs of health care fraud in the U.S. are more ...

Women and the Affordable Care Act
September 29, 2013

Women make about 80% of the health-care decisions for their families, utilize more health care than men, and are the more likely to be the care givers when a family ...

U.S. Health Care Costs: Disentangling Underlying Trends from the Effects of the Affordable Care Act
August 2, 2013

During the health reform discussions leading up to the passage of the Affordable Care Act (“ACA”), there was a lot of talk about the costs of health care services in ...

Health Care Costs and Value: An International Perspective
July 20, 2013

During the recent debates over the Affordable Care Act (“ACA,” or Obamacare) a commonly raised issue was that U.S. health care does not offer much in the way of “value ...

Tobacco Butts and Litter Costs
June 18, 2013

Tobacco product litter is one of the most ubiquitous forms of litter, accumulating in increasingly large numbers on streets, highways, sidewalks, beaches, storm water drains, waste treatment plants, parks and ...

Training the Health Economics and Outcomes Research Workforce of the Future: Opportunities for Program Development in Colleges and Universities
June 18, 2013

The health care landscape in the U.S. has been changing rapidly in the past 20 years, a phase of evolution that began with the reluctance of private employers to continue ...

Nobody Pays Retail: A Primer on Valuing Medical Care Bills
March 21, 2013

In most markets and in most industries, the prices paid by consumers (or businesses, in the case of business-to-business transactions), are not randomly made up by sellers. To be sure, ...

Using Publicly-Available Health Care Databases to Value & Price Medical Care Services
March 21, 2013

In the United States, a variety of “usual, customary and reasonable” (UCR) databases are used by health care entities to benchmark their fees (in the case of health care providers) ...

The Declining Health of the Local Market: When and How Should Your Health Care Business Expand into New Markets
March 21, 2013

A large proportion of our nation’s health care infrastructure is located in urban markets with declining population. For example, according to the U.S. Census, cities with the largest population decline ...


NEWS

New date- Tuesday, May 9th. AHE Presents: Symposium on Emerging Trends in U.S. Health Economic Evaluation: A Closer Look at the Role of Cost Effectiveness in U.S. Market Access, Tuesday May 9th in Morristown, NJ

CEO John Schneider will be speaking at Research! America’s Medical Innovation 101 February briefing on Capitol Hill with Dr. Keith R. Yamamoto, Director of Precision Medicine at the University of California San Francisco, Dr. Joe V. Selby, Executive Director at PCORI, and others.

Avalon Health Economics will be attending ISPOR Vienna, October 29th-November 2nd

John Schneider & Andrew Briggs will be teaching the Economics of Diagnostics Introduction Course on Sunday afternoon (1:00pm-5:00pm). Come say hi or sign up for the course! Let us know if you would like to schedule a time to meet in Vienna.

Analysis of Dental and Vision Plan Non-Covered Services and Materials Mandates and the Projected Role of H.R. 3323 in the Vision and Dental Markets
April 27, 2016

Our research found that for doctors of optometry and dentists in both states, even after the enactment of laws barring NCS mandates, the vast majority of providers continued to offer normal discounts and receive payments from patients that were below their charged amounts. Thus, the laws had no effect on the providers—they continued billing their "usual, customary and reasonable” (UCR) amounts and continued receiving amounts up to 50% less than their charged amounts, just as in the years prior to the NCS laws. It is clear from the findings that the providers were not “overcharging” for the services before the NCS laws and they continue to not overcharge for the services in the presence of the NCS laws.
(Click here to download this report)

Avalon CEO John Schneider presented at BMO Capital Markets’ “The Year Ahead in Healthcare: Products, Payment and Politics” on December 15, 2015
December 29, 2015

Avalon CEO John Schneider, Ph.D. presented at BMO Capital Markets’ “The Year Ahead in Healthcare: Products, Payment and Politics” on December 15, 2015. The day-long symposium was focused on markets ...

Philipp Schuetz joins Avalon Health Economics as a Clinical Director
November 27, 2015

Avalon Health Economics is happy to announce the addition of Philipp Schuetz, MD, MPH as our Clinical Director. He is a board-certified internist and endocrinologist. He has broad clinical and ...

CEO John Schneider presents at Barclays HealthCare Symposium
November 23, 2015

CEO John Schneider presented at the Barclays HealthCare Symposium on 11/20 on the topic of Increasing Need to Demonstrate Economic Value in Medtech.

Avalon’s Ivana Stojanovic will be attending the AdvaMed 2015 Med Tech Conference next week in San Diego, CA
October 1, 2015

The annual AdvaMed Med Tech Conference is the leading MedTech Conference in North America, bringing more than 1,000 companies together to exchange knowledge and ideas on business development, capital formation, ...

Avalon Health Economics at the European Congress of ISPOR, Milan, Italy
August 11, 2015

Avalon Health Economics will be presenting in several venues at the 18th Annual European Congress of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) in Milan, 7-11 November 2015 at ...

Avalon at ISPOR: John Schneider, Cara Scheibling, and Ivana Stojanovic will be attending the annual meeting of the International Society of Pharmacoeconomics and Outcomes Research in Philadelphia this week, 5/16 – 5/20
May 14, 2015

Avalon at ISPOR: John Schneider, Cara Scheibling, and Ivana Stojanovic will be attending the annual meeting of the International Society of Pharmacoeconomics and Outcomes Research in Philadelphia this week, May 16 ...

Avalon CEO John Schneider presents on “The Economics of Molecular Diagnostics” at the University of California Berkeley
April 27, 2015

Avalon CEO John Schneider presents on “The Economics of Molecular Diagnostics” at the University of California Berkeley’s School of Public Health. The lecture covered the basics of molecular diagnostics followed ...

Avalon team publishes study of the U.S. cost impact of procalcitonin testing in acute respiratory infections
February 26, 2015

Avalon team publishes study of the U.S. cost impact of procalcitonin testing in acute respiratory infections. The full article is accessible here. In the inpatient setting, the costs of procalcitonin ...

John Rizzo, PhD, joins Avalon Health Economics as a Consultant
September 13, 2014

John Rizzo, PhD, joins Avalon Health Economics as a Consultant. In addition to his role as Consultant with Avalon Health Economics, Dr. Rizzo is Professor of Economics and Preventive Medicine ...

CEO John Schneider presented at Nordic Life Science Days in Stockholm, Sweden on the economic evaluation of pharmaceutical drugs, medical devices, and diagnostics.
September 9, 2014

CEO John Schneider presented at Nordic Life Science Days in Stockholm, Sweden on the Economic Evaluation of pharmaceutical drugs, medical devices, and diagnostics. Nordic Life Science Days attracts leading decision makers ...

Ivana Stojanovic, MA, has joined Avalon Health Economics as a Health Economist
September 5, 2014

Ivana Stojanovic, MA, has joined Avalon Health Economics as a Health Economist. Ivana has several years of experience in economics consulting, and has expertise in conducting data analysis and research ...

Avalon Health Economics will be attending Nordic Life Science Days 2014, Stockholm, Sweden, September 7-9
July 18, 2014

Avalon Health Economics will be attending Nordic Life Science Days 2014, Stockholm, Sweden, September 7-9. Avalon will present “Establishing the Value of New Drugs, Devices & Diagnostics” (See Presentation). The NLSD ...

Noemi Kiss and Azal Ahmadi join Avalon Health Economics
July 7, 2014

Noemi Kiss is a Senior Health Economist with Avalon. She recently earned her MSc in Health Economics from the University of York (United Kingdom). Prior to York, Ms. Kiss was ...

James Robinson joins Avalon Health Economics as a Director
July 7, 2014

James Robinson joins Avalon Health Economics as a Director. Jamie is the Leonard D. Schaeffer Professor of Health Economics and Director of the Berkeley Center for Health Technology (BCHT) at ...

Watch Avalon’s presentation at EuroMedtech in Linz, Austria in May 2014 entitled “Establishing the Value of New Drugs, Devices, & Diagnostics”
July 7, 2014

Click here to view the presentation

Avalon at ISPOR: John Schneider and Cara Scheibling will be attending the annual meeting of the International Society of Pharmacoeconomics and Outcomes Research in Montreal next week, 6/1-6/4
May 31, 2014

Avalon at ISPOR: John Schneider and Cara Scheibling will be attending the annual meeting of the International Society of Pharmacoeconomics and Outcomes Research in Montreal next week, June 1 through June ...

Avalon will be attending and presenting at the EuroMedtech conference in Linz, Austria, May 7-8. The topic will be on economic evaluation of devices and diagnostics through the product lifecycle
May 5, 2014

Avalon will be attending and presenting at the 6th Annual EuroMedtech conference in Linz, Austria, May 7-8. The topic will be on economic evaluation of devices and diagnostics through the ...

New AHE publication: “Epidemiology and Economic Burden of Conjunctivitis: A Managed Care Perspective”
April 1, 2014

Conjunctivitis is a common condition of the eye that occurs worldwide and affects all ages and social strata, affecting more than 2 percent of the population. It is caused by ...

Michael J. Lacey, MSc, has joined Avalon Health Economics as a Senior Consultant focusing on Economic Modelling & Value Strategy
February 3, 2014

Michael J. Lacey, MSc, has joined Avalon Health Economics as a Senior Consultant focusing on Economic Modelling & Value Strategy. He also works as an independent health economics consultant. He ...

Megan Modic joins Avalon as a Research Assistant
November 25, 2013

Joining us recently is Megan Modic, who will provide research assistance on a variety of projects. Ms. Modic is currently earning her Bachelor’s degree in Honors Economics and Environmental Science ...

Avalon CEO John Schneider spoke at the 6th Annual Latin American & Canada Clinical Laboratory Symposium, Cartagena, Columbia, October 16-17, organized by Abbott Diagnostics. The title of his talk was “Economics of Cancer Biomarkers: Cost Effectiveness of HE4 in Clinical Decision Making.”
October 21, 2013

Avalon CEO John Schneider spoke at the 6th Annual Latin American & Canada Clinical Laboratory Symposium, Cartagena, Columbia, October 16th and 17th. The title of his talk was “Economics of ...

Avalon Health Economics CEO John Schneider presented at the annual Truck Safety and Litigation Seminar hosted by Marcello & Kivisto LLC law firm
October 12, 2013

Avalon Health Economics CEO John Schneider presented at the Truck Safety and Litigation Seminar hosted by Marcello & Kivisto LLC law firm in April 2013. In his presentation Dr. Schneider ...

Two new consultants join Avalon Health Economics: Jeff Kamil, MD (U.S. Market Access and Reimbursement) and Stephanie Wels (Research Assistant)
September 6, 2013

Avalon Health Economics is happy to announce the addition of two new consultants to our panel. Jeff Kamil, MD, joins us in the area of U.S. market access and reimbursement. ...

AHE presents at the 12th Annual Meeting of Physician Hospitals of America, Austin, TX “What Do We Know about the Effects of Hospital Ownership?”
March 20, 2013

AHE presents at the 12th Annual Meeting of Physician Hospitals of America, Austin, TX “What Do We Know about the Effects of Hospital Ownership?”

Publication: The Economics of Cancer Biomarkers
March 19, 2013

Publication: The Economics of Cancer Biomarkers

Publication: Organizational Boundaries Of Medical Practice: The Case Of Physician Ownership Of Ancillary Services
March 14, 2013

Publication: Organizational Boundaries Of Medical Practice: The Case Of Physician Ownership Of Ancillary Services

Publication: Tobacco Litter Costs and Public Policy: A Framework and Methodology for Considering the Use of Fees to Offset Abatement Costs
March 14, 2013

Publication: Tobacco Litter Costs and Public Policy: A Framework and Methodology for Considering the Use of Fees to Offset Abatement Costs

'